Oral human papillomavirus and human herpesvirus-8 infections among human immunodeficiency virus type 1-infected men and women in Italy

Sexually Transmitted Diseases

Volumn 39, Issue 11, 2012, Pages 894-898

  Del Mistro, Annarosa ^a   Baboci, Lorena ^a   Frayle Salamanca, Helena ^a   Trevisan, Rossana ^a   Bergamo, Elisa ^a,b   Lignitto, Laura ^a   Sasset, Lolita ^c   Cecchetto, Maria Grazia ^c   Cattelan, Anna Maria ^c   Calabro', Maria Luisa ^a  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c Infectious Diseases   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN PAPILLOMAVIRUS TYPE 10; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 61; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 83; ITALY; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MOUTH INFECTION; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; VIRUS SHEDDING; VIRUS TYPING;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ALPHAPAPILLOMAVIRUS; ANTIBODIES, VIRAL; DNA, VIRAL; FEMALE; HERPESVIRUS 8, HUMAN; HUMANS; ITALY; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTORS; SALIVA; SARCOMA, KAPOSI; SEXUAL BEHAVIOR;

EID: 84867741668     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31826ef2da     Document Type: Article

References (31)

1. Monk BJ, Tewari KS. The spectrum and clinical sequelae of human papillomavirus infection. Gynecol Oncol 2007; 107:S6YS13.
2. Marur S, D'Souza G, Westra WH, et al. HPV-associated head and neck cancer: A virus-related cancer epidemic. Lancet Oncol 2010; 11:781-789.
3. Schiffman M, Wentzensen N, Wacholder S, et al. Human papillo-mavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 2011; 103:1-16.
4. Strickler HD, Burk RD, Fazzari M, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 2005; 97:577-586. (Pubitemid 40723785)
5. Shiels MS, Pfeiffer RM, Hall HI, et al. Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007. JAMA 2011; 305:1450-1459.
6. Chaturvedi AK, Madeleine MM, Biggar RJ, et al. Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst 2009; 101:1120-1130.
7. Sikora AG, Morris LG, Sturgis EM. Bidirectional association of anogenital and oral cavity/pharyngeal carcinomas in men. Arch Otolaryngol Head Neck Surg 2009; 135:402-405.
8. Termine N, Giovannelli L, Matranga D, et al. Low rate of oral human papillomavirus (HPV) infection in women screened for cervical HPV infection in Southern Italy: A cross-sectional study of 140 immunocompetent subjects. J Med Virol 2009; 81:1438-1443.
9. Kreimer AR, Bhatia RK, Messeguer AL, et al. Oral human papillo-mavirus in healthy individuals: A systematic review of the literature. Sex Transm Dis 2010; 37:386-391.
10. Gillison ML, Broutian T, Pickard RKL, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012; 307:693-703.
11. Gillison ML. Oropharyngeal cancer: A potential consequence of concomitant HPV and HIV infection. Curr Opin Oncol 2009; 21:439-444.
12. D'Souza G, Fakhry C, Sugar EA, et al. Six-month natural history of oral versus cervical human papillomavirus infection. Int J Cancer 2007; 121:143-150. (Pubitemid 46753862)
13. Fakhry C, Sugar EA, D'Souza G, et al. Two-week versus six-month sampling interval in a short-term natural history study of oral HPV infection in an HIV-positive cohort. PLoS ONE 2010; 5(7):e11918.
14. Fakhry C, Rosenthal B, Clark DP, et al. Associations between oral HPV16 infection and cytopathology: Evaluation of an oropharyn-geal "Pap-test equivalent" in high-risk populations. Cancer Prev Rev 2011; 4:1378-1384.
15. Smith EM, Ritchie JM, Summersgill KF, et al. Human papillomavi-rus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst 2004; 96:449-455. (Pubitemid 38443648)
16. Gandhi M, Koelle DM, Ameli N, et al. Prevalence of human herpesvirus-8 salivary shedding in HIV increases with CD4 count. J Dent Res 2004; 83:639-643. (Pubitemid 41766074)
17. Miller CS, Berger JR, Mootoor Y, et al. High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. J Clin Microbiol 2006; 44:2409-2415. (Pubitemid 44109662)
18. Cameron JE, Mercante D, O'Brien M, et al. The impact of highly active antiretroviral therapy and immunodeficiency on human pap-illomavirus infection of the oral cavity of human immunodeficiency virus-seropositive adults. Sex Transm Dis 2005; 32:703-709. (Pubitemid 41682158)
19. Del Mistro A, Frayle Salamanca H, Trevisan R, et al. Triage of women with atypical squamous cells of undetermined significance (ASC-US): Results of an Italian multicentric study. Gynecol Oncol 2010; 117:77-81.
20. Bouvard V, Baan R, Straif K, et al. A review of human carcinogensV part B: Biological agents. Lancet Oncol 2009; 10:321-322.
21. Calabrò ML, Fiore JR, Favero A, et al. Detection of human herpesvirus 8 in cervicovaginal secretions and seroprevalence in human immunodeficiency virus type 1Yseropositive and Yseronegative women. J Infect Dis 1999; 179:1534-1537. (Pubitemid 29246605)
22. Gasperini P, Barbierato M, Martinelli C, et al. Use of a BJAB-derived cell line for isolation of human herpesvirus 8. J Clin Microbiol 2005; 43:2866-2875. (Pubitemid 40827965)
23. Boscolo-Rizzo P, Da Mosto MC, Fuson R, et al. HPV-16 E6 L83V variant in squamous cell carcinomas of the upper aerodigestive tract. J Cancer Res Clin Oncol 2009; 135:559-566.
24. Kreuter A, Wieland U. Human papillomavirus-associated diseases in HIV-infected men who have sex with men. Curr Opin Infect Dis 2009; 22:109-114.
25. Fakhry C, D'Souza G, Sugar E, et al. Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and Ynegative women. J Clin Microbiol 2006; 44:4479-4485. (Pubitemid 44937082)
26. Parisi SG, Cruciani M, Scaggiante R, et al. Anal and oral human papillomavirus (HPV) infection in HIV-infected subjects in northern Italy: A longitudinal cohort study among men who have sex with men. BMC Infect Dis 2011; 11:150.
27. Volter C, He Y, Delius H, et al. Novel HPV types present in oral papillomatous lesions from patients with HIV infection. Int J Cancer 1996; 66:453-456. (Pubitemid 26176766)
28. Syrjanen S. Human papillomavirus infection and its association with HIV. Adv Dent Res 2011; 23:84-89.
29. Broutian TR, He X, Gillison ML. Automated high throughput DNA isolation for detection of human papillomavirus in oral rinse samples. J Clin Virol 2011; 50:270-275.
30. Hansen TV, Simonsen MK, Nielsen FC, et al. Collection of blood, saliva, and buccal cell samples in a pilot study on the Danish nurse cohort: Comparison of the response rate and quality of genomic DNA. Cancer Epidemiol Biomarkers Prev 2007; 16:2072-2076. (Pubitemid 47621182)
31. Agorastos T, Chrisafi S, Lambropoulos AF, et al. Adeno-associated virus infection and cervical neoplasia: Is there a protective role against human papillomavirus-related carcinogenesis? Eur J Cancer Prev 2008; 17:364-368.